Sort
35,931 grants matching “parkinsons”
Unconventional protein secretion-mediated protein quality control in health and diseases
$1,101,807Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Mitochondrial Integrated Stress Response in Neurological Diseases
$1,101,750Giovanni Manfredi · Weill Medical Coll Of Cornell Univ · R35 · FY2025 · NS
Mitochondrial Integrated Stress Response in Neurological Diseases
$1,101,750Giovanni Manfredi · Weill Medical Coll Of Cornell Univ · R35 · FY2022 · NS
Mitochondrial Integrated Stress Response in Neurological Diseases
$1,101,748Giovanni Manfredi · Weill Medical Coll Of Cornell Univ · R35 · FY2023 · NS
Genetic Epidemiology of Parkinson's Disease
$1,101,278Columbia University Health Sciences · R01 · FY2005 · NS
ALZHEIMER'S DISEASE RESEARCH CENTER
$1,101,185Daniel C Marson · University Of Alabama At Birmingham · P50 · FY2007 · AG
Molecular Genetics Of Scrapie Pathogenesis
$1,100,933Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Genetic analysis in families with neurological disease
$1,100,056Andrew Singleton · National Institute On Aging · ZIA · FY2022 · AG
Replication of G-quadruplex DNA by translesion polymerases
$1,100,000Robert L Eoff · University Of Arkansas Medical Sciences Campus · · FY2024 · BIO
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
$1,099,853Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE
$1,099,653University Of Kentucky · P50 · FY2003 · NS
Neurostimulation of the Nucleus Basalis of Meynert for the cognitive-motor syndrome in Parkinson's disease
$1,099,271Helen Bronte-Stewart · Stanford University · UG3 · FY2023 · NS
A âCircuits-Firstâ Platform for Personalized Neurostimulation Treatment
$1,099,000Amit Etkin · Stanford University · DP1 · FY2017 · MH
A âCircuits-Firstâ Platform for Personalized Neurostimulation Treatment
$1,099,000Amit Etkin · Stanford University · DP1 · FY2018 · MH
A "Circuits-First" Platform for Personalized Neurostimulation Treatment
$1,099,000Amit Etkin · Alto Neuroscience, Inc. · DP1 · FY2019 · MH
Cortical-Basal Ganglia Speech Networks
$1,098,710Robert Mark Richardson · Massachusetts General Hospital · U01 · FY2024 · NS
Genetic Epidemiology of Parkinson's Disease
$1,098,704Karen S Marder · Columbia University Health Sciences · R01 · FY2006 · NS
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
$1,098,451Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Neural correlates for cortical and subcortical control of vocalization
$1,098,259Shahriar Sheikhbahaei · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Central Nervous System Drug Delivery Techniques
$1,098,114Russell Lonser · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
NIMH Instrumentation Core Facility
$1,097,917George Dold · National Institute Of Mental Health · ZIC · FY2016 · MH
Dual-hit hypothesis of aging-related DA dysfunction
$1,096,503Ann-Charlotte Esther Granholm-Bentley · Medical University Of South Carolina · P01 · FY2007 · AG
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
$1,096,131Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Development of a Nanoparticle-Based Gene Editing Technology for Neurological Applications
$1,096,057Krystof S Bankiewicz · Ohio State University · UH3 · FY2022 · NS
Regulation of mitochondrial transport and its impact on synaptic transmission
$1,095,679Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS